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As postsynaptic metabotropic subtype 1 (mGlu1) receptors are present in the thalamus, we have
investigated the effect of potentiating and antagonising mGlu1 receptors on responses of thalamic
neurones to noxious sensory stimulation. Extracellular recordings were made in vivo with multi-barrel
iontophoretic electrodes from single neurones in the thalamus of urethane-anaesthetised rats. Re-
sponses to iontophoretic applications of the Group I mGlu agonist 3,5-dihydroxy-phenylglycine (DHPG)
were selectively potentiated by co-application of the mGlu1 positive allosteric modulator Ro67-4853,
whereas they were selectively reduced upon co-application of the mGlu1 receptor orthosteric antago-
nist LY367385. This indicates that thalamic DHPG responses are mediated primarily via mGlu1 receptors,
consistent with the high postsynaptic levels of this receptor in the thalamus. Furthermore, potentiation
of DHPG responses by Ro67-4853 were greater when the initial DHPG response was of a low magnitude.
Ro67-4853 also potentiated responses of thalamic neurones to noxious thermal stimulation, whilst
having little effect on the baseline activity of nociceptive neurones. By contrast, nociceptive responses
were reduced by LY367385. In a further series of experiments we found that inactivation of somato-
sensory cortex by cooling resulted in a reduction of thalamic nociceptive responses. These results un-
derline the importance of mGlu1 receptors in the processing of sensory information in the thalamus,
particularly with respect to nociceptive responses. Furthermore, the involvement of mGlu1 receptors
may reﬂect the activity of descending cortico-thalamic afferents.
 2013 The Authors. Published by Elsevier Ltd.Open access under CC BY-NC-ND license.1. Introduction
The neurotransmitter pharmacology of nociceptive processing is
of great importance in our understanding of pain mechanisms and
therapy. Understanding of the neurotransmitters and receptors
involved in nociception is extensive at the level of the peripheral
nervous system and the spinal cord (Lesage, 2004; Millan, 1999).
However, at higher levels of the neuraxis, our knowledge is less
comprehensive. The ventrobasal thalamus (VB) is a pivotal pro-
cessing point for the integration of somatosensory information
ascending from the spinal cord with a prominent descending
cortico-thalamic input from Layer 6 of the correspondinguroscience, UCL Institute of
United Kingdom. Tel.: þ44 20
r Ltd.Open access under CC BY-NC-NDsomatosensory cortex (Sherman, 2012). Both of these pathways use
glutamate as their excitatory transmitter. Previous work from this
laboratory and others has shown that responses of thalamic neu-
rones to noxious peripheral stimuli are largely mediated by gluta-
mate receptors, in particular the ionotropic NMDA receptor (Bordi
and Quartaroli, 2000; Eaton and Salt, 1990; Kolhekar et al., 1997)
and the metabotropic glutamate (mGlu) receptors, mGlu1 and
mGlu5 (Eaton et al., 1993; Salt and Binns, 2000; Salt and Turner,
1998).
There are eight mGlu receptor subtypes (mGlu1-mGlu8) that
can be placed into three groups (Group I, II, III) based on sequence
homology, intracellular transduction cascade, and agonist/antago-
nist pharmacology (Niswender and Conn, 2010). Group I receptors
(mGlu1, mGlu5) are often (but not exclusively) localised post-
synaptically where they may couple to inositol phosphate meta-
bolism and enhance post-synaptic excitability via changes in Kþ
conductances and/or modulation of ionotropic glutamate receptors
(Niswender and Conn, 2010). In addition to selective agonists and
antagonists, a novel class of pharmacological agents acting at mGlu
receptors has more recently become available, the positive allo-
steric modulators (PAMs) (Nicoletti et al., 2011). PAMs act at sites on license.
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binding site and enhance the activity of receptors in response to
orthosteric agonists (Nicoletti et al., 2011). This has advantages in
that PAMs can be highly selective for single mGlu receptor subtypes
and can function to potentiate the physiological activation of re-
ceptors by endogenous glutamate. Both of these properties are
useful for the investigation of physiological processes. We have
shown that one such PAM, Ro67-4853 (Knoﬂach et al., 2001), can be
used in in vivo experiments to potentiate responses mediated via
mGlu1 receptors in an activity-dependent manner (Salt et al.,
2012). Thus, Ro67-4853 is an appropriate tool to investigate
possible mGlu1 involvement in thalamic nociceptive processing.
The present study aimed to investigate the involvement and
function of mGlu1 receptors in nociceptive processing in the thal-
amus. We have achieved this by potentiating mGlu1 receptor
mediated responses with the selective PAM Ro67-4853 and by
reducing mGlu1 receptor activation using the selective antagonist
LY367385 (Clark et al., 1997) whilst recording nociceptive re-
sponses of thalamic neurones. Furthermore, given the association
of mGlu1 receptors with cortico-thalamic pathways (Godwin et al.,
1996; Martin et al., 1992; Vidnyanszky et al., 1996), we investigated
the effect of somatosensory cortex inactivation on nociceptive re-
sponses of thalamic neurones. We show that it is possible to sub-
stantially change nociceptive responses of thalamic neurones by
increasing or decreasing the degree of mGlu1 receptor activation
and that nociceptive responses of thalamic neurones are dependent
upon a functional cortico-thalamic projection. This is important in
understanding sensory processing and the design of novel anal-
gesic therapies, and underlines the critical role of mGlu1 receptors
in sensory processing in the thalamus.
2. Methods
Experiments were carried out in male adult Wistar rats (270e400 g) anaes-
thetised with urethane (1.2 g/kg, I.P.), as detailed previously (Salt, 1987; Salt and
Binns, 2000; Salt et al., 2012). Animals were purchased from Harlan (UK) and
were housed on a 12 h light/dark cycle with unlimited access to food and water. All
procedures were subject to local ethical committee review, were approved by the
Home Ofﬁce (UK) and were in accordance with the Animals (Scientiﬁc Procedures)
Act 1986. Electroencephalogram and electrocardiogramweremonitored throughout
and anaesthesia was maintained by additional I.P. administration of urethane as
required. An approximately 5 mm-square unilateral craniotomy centred over the
thalamus (3 mm lateral to the midline, 5 mm rostral to the inter-aural line (Paxinos
and Watson, 1988)) was made and the dura resected to expose the surface of the
cortex. In addition to overlying the thalamus, this area of cortex contains the hin-
dlimb and trunk/tail representation of the S1 somatosensory cortex (Chapin and Lin,
1984). In some experiments the craniotomy was surrounded by a small open
chamber cemented to the skull that could be ﬁlled with either mineral oil or
physiological saline; in the remaining experiments the surface of the brain was
protected by agar (2% in physiological saline).
Recording electrodes were stereotaxically lowered into the thalamus using a
stepping microdrive. Extracellular recordings were made from single neurones in
the VB and immediately dorsal thalamus using either tungsten-in-glass electrodes
or, for pharmacological experiments, the central barrel of seven-barrel glass ionto-
phoretic electrodes. Single neurone action potential spikes were gated using a
hardware spike-discriminator whose output pulses were timed and recorded by a
CED1401 interface and computer system with Spike2 software. The amplitude and
shape of the gated action potentials were monitored throughout the recording
session. Neurones were identiﬁed on the basis of their stereotaxic location
(AP þ5.0 mm from lambda, Lateral 2.9 mm from midline, Depth 4.6e5.2 mm from
surface) and their responses to somatosensory (nociceptive and non-nociceptive)
stimuli, as described previously (Guilbaud et al., 1980; Peschanski et al., 1980,
1983; Salt and Binns, 2000). Nociceptive responses were evoked by immersion of
part of either the contralateral hindpaw or the tail inwater of 52C for 20 s. Responses
to such stimuli were typically increases in action potential ﬁring during the course of
the stimulus and outlasting the stimulus by up to 2 min, as described previously
(Peschanski et al., 1980). Similar response proﬁles were observed irrespective of the
recording electrode type or the type of craniotomy preparation. Noxious stimuli
were repeated at regular 5-min intervals in experiments where modulation of
nociceptive responses was investigated (see below).
For pharmacological experiments, substances under investigation were applied
in the recording location from the six outer barrels of the electrode using the
iontophoretic technique (Stone, 1985) with a Neurophore BH2 system. Each of theouter barrels contained a selection from one of the following substances: NMDA (N-
methyl-D-aspartate, 50 mM, pH 8.0 in 150 mM NaCl); AMPA (S-alpha-Amino-3-
hydroxy-5-methyl-4-isoxazolepropionate, 50 mM, pH 8.0 in 150 mM NaCl);
LY367385 (100mM inwater, pH 8.0); DHPG (S-3,5-dihydroxy-phenylglycine, 50mM
in 150 mM NaCl, pH 3.5); Ro67-4853 (2 mM in 10% DMSO in 150 mM NaCl, pH 7.5),
vehicle control (10% DMSO in 150 mM NaCl, pH 7.5), Pontamine Sky Blue dye (2% in
1 M NaCl), 1 M NaCl. All pharmacological agents were obtained from Tocris Biosci-
ence (UK), apart from Ro67-4853, which was a gift from Roche Pharmaceuticals
(Switzerland). DHPG was ejected as a cation, all other substances were ejected as
anions. Agents were prevented from diffusing from the iontophoresis barrel by
applying a retaining current (5e15 nA) of opposite polarity to the ejection current.
Automatic current balancing was routinely performed through the 1 M NaCl-
containing barrel. In experiments where the effects of either the PAM or antago-
nist on agonist responses were evaluated, regular repeated cycles of agonist ejec-
tions were set up and initiated by the computer systemwhich also produced online
peristimulus-histograms (PSTHs) of single-neurone activity. Agonist ejection pa-
rameters were adjusted so as to produce sub-maximal responses. The effects of the
PAM or antagonist on agonist effects were assessed by continuous concurrent
iontophoretic application of these agents during several cycles of agonist ejection.
Thus, although it is not possible to give absolute tissue concentrations of agents, we
are conﬁdent that the doses used are within the range of producing physiologically
relevant and pharmacologically selective effects. In experiments where the effects of
either the PAM or antagonist on nociceptive responses were investigated, these
agents were ejected with similar iontophoretic parameters to those found to be
effective on responses to agonists.
In experiments designed to investigate the inﬂuence of cortical activity on
thalamic responses, we inactivated the S1 somatosensory cortex by cooling (Clemo
and Stein, 1986; Diamond et al., 1992). After responses to noxious stimuli of a
neurone were established, the warm physiological saline in the well overlying the
cortex was gently aspirated and replaced with chilled (4C) saline every 2e3 min for
up to 10 min and the effect on the nociceptive responses noted. Finally, the saline
was replaced with warm saline and nociceptive responses were further recorded. In
separate experiments, a miniature thermocouple was inserted into the cortex to a
depth of 1mm and it was found that the cooling procedure reduced the temperature
at this point to 15C. When the thermocouple was moved down into the body of the
thalamus, no change in temperature could be detected when the cortical cooling
procedure was performed.
Responses to agonists or noxious stimuli were quantiﬁed as the number of ac-
tion potentials evoked by agonist ejection or stimulus, from which PSTHs were
plotted. The effects of the PAM, the antagonist, or cortical inactivation on these re-
sponses were assessed by calculating the agonist or stimulus response during these
experimental manipulations as a percentage of the response under control condi-
tions. In the case of nociceptive responses, distinct ‘initial’ and ‘maintained’ response
components were computed: the initial component was the number of action po-
tential spikes evoked during the nociceptive stimulus whereas the maintained
response was the number of action potential spikes occurring during the minute
immediately after the stimulus. Data from individual neurones were used to
compute mean values of effects (s.e.m.). Statistical comparisons of these values
under control conditions and during experimental manipulations were made using
theWilcoxon Signed Rank test. Results were deemed to be signiﬁcant when P< 0.05.
3. Results
Recordings were made from 25 neurones that were charac-
terised as nociceptive thalamic neurones on the basis of their ste-
reotaxic location and responses to noxious stimuli directed at the
contralateral limbs and tail as described previously (Guilbaud et al.,
1980; Peschanski et al., 1980). Typically these neurones were
located above or lateral to the vibrissal representation in the VB
complex, had low spontaneous ﬁring rates (0.05e2.4 spikes per
second) and responded to noxious stimuli with a graded increase in
ﬁring rate that outlasted the stimulus, as described previously
(Eaton and Salt, 1990; Guilbaud et al., 1980; Peschanski et al., 1980;
Salt and Binns, 2000).
Iontophoretic application of the Group I agonist DHPG (20e
80 nA, 10e20 s) caused increases in action potential ﬁring rate of
the thalamic neurones, as previously described (Salt and Binns,
2000; Salt et al., 2012). Previous work from this laboratory has
indicated that this excitatory response to DHPG is mediated pre-
dominantly via mGlu1 receptors (Salt and Binns, 2000). In order to
evaluate the ability of Ro67-4853 to potentiate mGlu1 receptor
mediated responses of nociceptive thalamic neurones, we co-
applied this PAM (50e150 nA) during regular ejections of DHPG.
We found that this potentiated the DHPG responses to 282  87%
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ceptive neurones (Fig. 1). On vibrissae-responsive (non-nocicep-
tive) neurones a similar effect (267  33% of control, n ¼ 19,
P < 0.01) was seen. This effect was typically reversible within
10min of the termination of the Ro67-4853 application. It appeared
that the greatest degree of potentiation could be achievedwhen the
control response to DHPG was relatively low in terms of increased
ﬁring of action potentials. This was borne out by the apparent in-
verse correlation between the potentiating effect of Ro67-4853 and
themagnitude of the control response to DHPG (P< 0.001) (Fig.1C).
These ﬁndings indicate that Ro67-4853 can potentiate the
mGlu1-receptor-mediated responses to DHPG of thalamic noci-
ceptive neurones, in agreement with our previous ﬁndings on
vibrissa-responsive thalamic neurones (Salt et al., 2012). When
Ro67-4853 was applied during noxious stimulation on 6 thalamic
neurones, the nociceptive responses were potentiated to an overall
247  99% of control values (P < 0.05), with a more pronounced
effect on the latter (maintained) components of the nociceptive
responses than on the initial component in 5 of the 6 neurones
(Figs. 2 and 3A). The effect of Ro67-4853 reversed upon termination
of the ejection. On 4 of these 6 neurones the responses to repeated
noxious stimuli were further recorded during co-application of the
mGlu1 receptor antagonist LY367385 (20e40 nA) (Fig 2). This
antagonist reduced the nociceptive responses in these neurones
and in a further 5 neurones where Ro67-4853 had not been tested
LY367385 had a similar effect. Overall, on the 9 neurones where
nociceptive responses were studied with LY367385, the antagonist
reduced responses to 17  9% of control levels with little difference
in effect between initial and maintained components of the
response proﬁles (Fig. 3B). In order to verify the selectivity of
LY367385 on this population of neurones, we recorded from 82 min
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Fig. 1. Potentiation of DHPG responses by Ro67-4853. A e Action potential ﬁring rate histog
DHPG (indicated by marker bars). Co-application of Ro67-4853 (indicated by marker bar) p
effect of Ro67-4853 on DHPG responses. Bars represent mean % change from control (100%)
after termination of PAM application. Ro67-4853 produced a similar signiﬁcant potentiation
neurones. C e Scatter plot (logarithmic axes) of potentiation (% control) by Ro67-4853 vers
greater potentiations when the initial response to DHPG was relatively small in terms of ﬁneurones that were excited by regular ejections of DHPG, NMDA
and AMPA. On all of these neurones, co-application of LY367385
reduced DHPG responses (to 6  5% of control) while having little
effect on responses to either NMDA or AMPA (Fig. 4).
In view of the possibility that the cortico-thalamic projection
contributes to the mGlu1 receptor-mediated component of
thalamic nociceptive responses, we carried out a set of experiments
where we inactivated somatosensory cortical activity by cooling
the cortex whilst recording thalamic nociceptive responses. In
these experiments, there was a substantial reduction in the
magnitude of nociceptive responses of thalamic neurones to
14  8% of control (n ¼ 5) (Fig. 5). Responses returned to near-
control levels in all cases once the cortical cooling procedure had
been terminated.
4. Discussion
We have previously reported that local application of the mGlu1
receptor PAM, Ro67-4853, can enhance DHPG-evoked excitations
of somatosensory vibrissae-responsive VB neurones (Salt et al.,
2012). The primary ﬁnding of the present study is that this PAM
has similar effects on nociceptive thalamic neurones and is able to
substantially enhance nociceptive responses of these neurones.
Furthermore, in an extension to our previous studies, we have
shown that nociceptive thalamic responses are sensitive to antag-
onism by a selective mGlu1 receptor antagonist (LY367385), and
ﬁnally that the nociceptive responses are dependent on an intact
cortical input.
Inactivation of the sensory cortex has been used as a means of
investigating cortical inﬂuences on subcortical areas in a variety of
species and sensory systems (Binns and Salt, 1996; Clemo and Stein,C
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Sterling, 1969) including the rat somatosensory cortex (Diamond
et al., 1992; Yuan et al., 1985): cooling of somatosensory cortex
appears to be a useful means of producing a reversible inactivation
to study corticofugal inﬂuences on somatosensory thalamic pro-
cessing in the rat (Diamond et al., 1992). Interestingly, Diamond
et al. (1992) found that such a procedure had little effect on
vibrissa responses of ventrobasal thalamus neurones although re-
sponses of Posterior Group (POm) thalamic neurones were
reduced. In the present study, using similar procedures, we found
that nociceptive responses were profoundly reduced by cortical
inactivation, and this might at ﬁrst reﬂect a greater involvement of
cortico-thalamic circuitry in nociceptive responses compared to
vibrissal responses but might also reﬂect patterns of vibrissal input
(Salt et al., 2012).
Ro67-4853 has been documented as a PAM that is selective at
mGlu1 receptors across a range of species with an EC50 of
approximately 0.1 mM (Knoﬂach et al., 2001). This selectivity is
borne out by our present ﬁnding that Ro67-4853 can enhance re-
sponses to DHPG in a similar manner to the potentiation seen on
hippocampal neurones in vitro (Knoﬂach et al., 2001), and is
consistent with the high levels of expression of mGlu1 receptors
compared to mGlu5 receptors in the thalamus (Martin et al., 1992;
Neto et al., 2000; Shigemoto et al., 1992). Our ﬁndings that noci-
ceptive responses are potentiated by an mGlu1 PAM and reduced
by an mGlu1 antagonist provide compelling evidence to suggest
that mGlu1 receptors are activated during this physiological stim-
ulation. Themost likely physiological source of themGlu1 receptor-
mediated component of thalamic responses is the Layer 6 cortico-
thalamic input to thalamic neurones in view of the anatomical
location of these receptors on distal dendrites close to terminals
likely of cortical origin (Godwin et al., 1996; Martin et al., 1992;
Vidnyanszky et al., 1996). This is further supported by in vitro
electrophysiological experiments where stimulation of the cortical
input to thalamic neurones that can be reduced with mGlu1 an-
tagonists (Reichova and Sherman, 2004; Turner and Salt, 2000).
DHPG NMDA AMPA80
0
S
pi
ke
s/
s
80
0
80
0
1 min 500ms bins
ert261b
Control
LY367385
Recovery
A B
0
20
40
60
80
100
120
140
DHPG
Control
LY367385
Recovery
(n=8)
%
 C
on
tro
l
NMDA AMPA
Effect of LY367385 on responses to 
DHPG, NMDA and AMPA
**
Fig. 4. Selective antagonism of DHPG by LY367385. A e Action potential ﬁring rate histograms (500 ms time bins) of a single VB neurone, showing excitatory responses to ap-
plications of DHPG, NMDA and AMPA (as indicated by bars above the records). Upper record is a control sequence, the central record is taken during the co-application of LY367385,
the lower record shows recovery from the effects of the antagonist. Note that LY367385 blocked responses to DHPG with little effect on responses to either NMDA or AMPA. B e
Summary histograms showing the effects of LY367385 on the three agonists for data from 8 neurones. ** P < 0.01.
T.E. Salt et al. / Neuropharmacology 79 (2014) 405e411 409Consistent with this, we have found in the present study that
inactivation of the somatosensory cortex reduces the nociceptive
responses of thalamic neurones. Taken together, this suggests that
responses of thalamic neurones to noxious stimuli are a conse-
quence of recruitment of cortical circuitry in addition to sensory
input. It is of interest that a similar suggestion has been made forControl
Inactivate Cortex
2 mins
Recovery
3mins
Recovery
8mins
52C80
0
80
0
80
0
80
0
S
pi
ke
s/
s
500ms bins
ert172a
1 min
A
Fig. 5. Effects of cortical inactivation on nociceptive responses. A e Action potential ﬁring
regular noxious stimuli (marker bars, 52C). The upper record is a control response, the second
the inactivation over several minutes. B e Summary histograms showing the effects of corthalamic responses in the somatosensory vibrissal system and the
visual system in vivo and that the degree of recruitment may
depend on the stimulus parameters that are used (Rivadulla et al.,
2002; Salt et al., 2012).
It is evident that manipulation of mGlu1 activation either in an
upward (with PAM) or downward (with antagonist) direction has a0
20
40
60
80
100
120
(n=5)
Modulation of Nociceptive Responses 
by Cortical Inactivation
%
 C
on
tro
l
B
*
rate histograms (500 ms time bins) of a single VB neurone, showing the responses to
record is taken during cortical inactivation, the lower two records show recovery from
tical inactivation for data from 5 neurones. * P < 0.05.
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in vivo. The substantial inﬂuence that cortical inactivation has on
these responses further underlines this. This may at ﬁrst sight seem
somewhat surprising, as the apparent direct contribution of mGlu1
receptors to synaptic responses in thalamic slice experiments ap-
pears to be relatively small (Turner and Salt, 2000). This may in part
be due to the relatively distal dendritic location of mGlu1 receptors
(Godwin et al., 1996; Martin et al., 1992; Vidnyanszky et al., 1996),
but it is also known that mGlu1 receptor activation can have very
non-linear effects on thalamic neuronal membrane properties
(McCormick and Von Krosigk, 1992; Turner and Salt, 2000;
Williams et al., 1997), and this would enhance responses medi-
ated via ionotropic receptors (e.g. NMDA or AMPA receptors). In
addition direct positive modulation of NMDA receptors by mGlu
receptors has been demonstrated, and we have previously shown
that low, subthreshold, levels of mGlu1 activation can enhance
thalamic neurone responses NMDA and AMPA receptor activation
(Salt and Binns, 2000). Finally, it has been shown that activation of
the mGlu1-phospholipase C beta 4 (PLC beta 4) molecular pathway
can enhance the tonic ﬁring mode of thalamic nociceptive neuro-
nes (Cheong et al., 2008). Thus mGlu1 receptors appear to be crit-
ically placed to play a dynamic role in controlling the responses to
nociceptive stimuli of thalamic neurones. However, it is important
to note that there is evidence to suggest some involvement of
mGlu5 receptors in thalamic nociceptive responses, although this is
unlikely to arise from cortical input (Salt and Binns, 2000). Inter-
estingly, both Ro67-4853 and LY367385 appeared to have a much
greater inﬂuence on thalamic nociceptive responses than the ef-
fects they produced on vibrissal responses reported by ourselves
previously (Salt et al., 2012); this is parallelled by the large effect of
cortical inactivation on nociceptive responses that we have
described compared to the lack of effect of cortical inactivation on
vibrissal responses of ventrobasal thalamus neurones (Diamond
et al., 1992).
In conclusion, our ﬁndings demonstrate the pivotal contribution
that mGlu1 receptors make to nociceptive processing at the
thalamic level. This is important in terms of understanding noci-
ceptive mechanisms and in the design of novel therapeutics.
However, given that mGlu1 receptors have been implicated in
synaptic plasticity (Nicoletti et al., 2011; Niswender and Conn,
2010), our ﬁndings suggest that plastic mechanisms may be acti-
vated under these conditions in vivo, and may underlie changes
that may occur in chronic pain conditions. Moreover they underline
the role that the cortical feedback may have in chronic pain and
highlight the potential for development of pharmacological inter-
vention targeting these mechanisms in the clinical treatment of
chronic pain.
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